American Society for Clinical Investigation Archive — Page 1 of 2

January 30, 2024

Four physician-scientists from VUMC receive national early-career awards

Four Vanderbilt physician-scientists have received awards from the American Society for Clinical Investigation.

By Bill Snyder
December 19, 2023

Three from VUMC elected to ASCI

Three physician scientists from Vanderbilt University Medical Center have been elected this year to membership in the American Society for Clinical Investigation, one of the nation’s oldest and most respected medical honor societies.

By Bill Snyder
February 9, 2023

American Society for Clinical Investigation honors 10 Vanderbilt physicians

By Bill Snyder
VUMC faculty members attending the meeting of the American Society for Clinical Investigation included, from left, Wesley Ely, MD, MPH, Patrick Hu, MD, PhD, Lorraine Ware, MD, Kimryn Rathmell, MD, PhD, Consuelo Wilkins, MD, MSCI, Christopher Williams, MD, PhD, Lori Jordan, MD, PhD, Natasha Halasa, MD, MPH, ASCI Council Member Julie Bastarache, MD, Eric Tkaczyk, MD, PhD, and James Crowe Jr., MD.
April 21, 2022

VUMC a national leader in physician-scientist training

Physician-scientists from Vanderbilt University Medical Center were well represented at the recent annual meeting of the American Society for Clinical Investigation (ASCI), Association of American Physicians (AAP) and the American Physician-Scientist Association.

By Bill Snyder
April 13, 2022

Arroyo, Terker receive new awards from ASCI

Juan Pablo Arroyo, MD, PhD, instructor of Medicine in the Division of Nephrology and Hypertension, and Andrew Terker, MD, PhD, research fellow in Nephrology, each received an inaugural 2022 Emerging Generation Award from the American Society for Clinical Investigation.

By Emily Stembridge
Corina Borza, PhD, left, Ambra Pozzi, PhD, and colleagues are studying a certain cell surface receptor’s role in the process that leads to kidney failure.
February 2, 2022

VUMC study raises hope for improving treatment of kidney disease

Vanderbilt research has revealed an important mechanism in the kidney by which a cell surface receptor known as DDR1 fans the flames of inflammation and fibrosis that ultimately lead to kidney failure.

By Bill Snyder